News

Landmark International Brain Health Initiative Deploys NeuraLight's Biomarkers to Quantify Change in Brain Function

Clinical Trial Results Show NeuraLight Biomarkers Predict Functional Decline in People With Parkinson’s Disease

NeuraLight Wins Fast Company’s World Changing Ideas Award for Its Innovation in Brain Function Measurement

New Peer-reviewed publication: NeuraLight Biomarkers Reveal What Parkinson's Gold-Standard Measurement Scale Misses in a Study Led by the Scale's Own Developers

NeuraLight and Kariya Partner to Measure How Next-Generation GLP-1 Therapies Impact the Brain

NeuraLight and Teitur Trophics Announce Collaboration to Use Precision Biomarkers in TT-P34 Parkinson’s Disease Clinical Trial

NeuraLight Reaches Key Milestone with Completion of International Multicenter Parkinson’s Clinical Trial

NeuraLight Reveals the World-Class Scientific Leaders Helping to Advance Its Transformation of Disease Progression Measurement in Neurology

NeuraLight CEO Selected for 2025 Slice of Healthcare 50 Under 50 List

NeuraLight Nominated for the 2025 Prix Galien USA Award in Digital Health

NeuraLight and CHDI Foundation Collaborate to Advance Precision Eye Movement Biomarkers for Huntington's Disease

Renowned Parkinson’s Expert Prof. Olivier Rascol Appointed to Lead NeuraLight’s Scientific Advisory Board